Julie K. Brooks

Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms (CYP2C19, ABCB1, PON1), Noncompliance, Diet, Smoking, Co-Medications (Including Proton Pump Inhibitors), and Pre-Existent Variability in Platelet Function

Andrew L. Frelinger, Deepak L. Bhatt, Ronald Lee et al. · Journal of the American College of Cardiology · 2013 · 205 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

A Randomized, 2-Period, Crossover Design Study to Assess the Effects of Dexlansoprazole, Lansoprazole, Esomeprazole, and Omeprazole on the Steady-State Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Volunteers

Andrew L. Frelinger, Ronald Lee, Darcy J. Mulford et al. · Journal of the American College of Cardiology · 2012 · 150 citations

Medicine, Pharmacokinetics, Pharmacology +5

Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-d in advanced measurable pancreatic carcinoma.A gastrointestinal tumor study group report

Philip S. Schein, Philip T. Lavin, Charles G. Moertel et al. · Cancer · 1978 · 106 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Platelet Activation and Inhibition iN Sickle cell disease (PAINS) study

Andrew L. Frelinger, Joseph A. Jakubowski, Julie K. Brooks et al. · Platelets · 2013 · 59 citations

Medicine, Hematology, Pharmacology +17

Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms (CYP2C19, ABCB1, PON1), Non-Compliance, Diet, Smoking, Co-Medications (including Proton Pump Inhibitors), and Pre-Existent Variability in Platelet Function

Andrew L. Frelinger, Deepak L. Bhatt, Ronald Lee et al. · Blood · 2012 · 10 citations

Pharmacy, Pharmacokinetics, Pharmacology +17